eZono Gains Three Anesthesia Distributors at DAC 2009
Start of European Sales Expansion for Portable Ultrasound System in DACH Region’s Anesthesia Market
eZono Gains Three Anesthesia Distributors at DAC 2009
At the Deutsche Anästhesiecongress (DAC 2009) in Leipzig, eZono AG unveils three strategic agreements with anesthesia distributors. In Germany P.J. Dahlhausen & Co. GmbH will serve as eZono’s exclusive distributor. For Switzerland eZono has gained Theramed AG and for Austria Sanitas GmbH .
“This is an excellent start of our expansion in Europe. Since our partners’ specialists serve a relatively low number of hospitals per head, they support their clients daily, not just at system purchase. On top, their deep knowledge in anesthesia and intensive care enables our eZono™ 3000 ultrasound system to gain traction fast” says Robert Grüter, eZono’s Head of Sales & Marketing.
“As a result of our own nation-wide distribution network we know the market very well. Our customers are starting strongly to adopt sonography for regional anesthesia, now we can serve their demand with the innovative eZono™ 3000 ultrasound system.” says Ulrich Dahlhausen, CEO of P.J. Dahlhausen, Germany’s longest-serving anesthesia distributor.
“Due to the icon-based user interface and the workflow guidance, the eZono™ 3000 has an unprecedented ease of use. This enables us and our customers to adopt this sonography solution very effectively” adds Ludwig Bertignol, CEO of Sanitas GmbH.
“Our customers are very enthusiastic in particular about eZono’s Cue Cards , the patented multimedia training tools, which we believe will foster adoption of ultrasound-guided anaesthesia in Switzerland” concludes Severin Augstburger, Managing Director of Theramed.
About eZono
AG
eZono AG is a different kind of ultrasound company, one
that develops and produces its application-specific devices in Germany.
eZono was founded in July 2004 and is located in Jena. Its diversified
staff consists of 16 nations and is supported by more than 40 investors
globally.
About P.J.
Dahlhausen & Co. GmbH
Dahlhausen’s success is based on
four key principles: a large product offering, high quality, absolute
customer dedication and our strong experience.
About Sanitas
GmbH
Grounded on more than 50 years of experience, Sanitas
offers innovative solutions for medical and information technology in
Austrian anesthesia, intensive and emergency care markets.
About Theramed
AG
Theramed serves the Swiss anesthesia and intensive care
markets for 25 years with innovative medical products. Safety for our
patients – simplicity for me.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
eZono AG
Andre Jaekel
+49 3641 876 1730
press@ezono.com
or
P.J.
Dahlhausen & Co. GmbH
Verena Dahlhausen
+49 2236 39 13 0
v.dahlhausen@dahlhausen.de
or
Theramed
AG
Severin Augstburger
+41 41 228 20 20
info@theramed.ch
or
Sanitas
GmbH
Gerhard Bertignol
+43 662 852186-0
sanitas@sanitas.at
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ericsson Joins Avanci Video as a Licensor8.4.2025 11:00:00 CEST | Press release
Momentum Continues for Avanci Video, the One-Stop Patent Licensing Solution for Internet Streaming Avanci Video, the simple and efficient licensing solution for internet streaming services, today welcomed Ericsson as a new licensor. Built from its ongoing investments in multimedia technologies, Ericsson owns a substantial portfolio of essential patents for video technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250408314721/en/ Avanci Video is the one-stop patent licensing solution for internet streaming services. (Graphic: Avanci) Avanci Video offers the option of a single, comprehensive license for internet streaming providers, covering the latest video technologies—AV1, H.265 (HEVC), H.266 (VVC), MPEG-DASH, and VP9. Spanning the relevant patent portfolios of 32 (and growing) licensors for multiple technology standards in one agreement, Avanci Video simplifies the licensing process, making it more efficient and
Celonis and Smurfit Westrock Unlock Significant Value by Optimizing Inventory Management with Process Intelligence and AI8.4.2025 10:00:00 CEST | Press release
Celonis, the global leader in Process Mining and Process Intelligence, today shared the results of an innovative AI-driven solution that is optimizing Smurfit Westrock’s inventory management, unlocking significant value. Enabled by the Process Intelligence Graph and built on the Celonis Process Intelligence Platform, the AI Copilot is a prime example of how Process Intelligence empowers Artificial Intelligence to deliver tangible business impact. Building on the impressive achievements, Smurfit Westrock is expanding its collaboration with Celonis to optimize additional core business processes across its global operations. Unlocking AI’s Full Potential Through Process Intelligence With operations spanning the globe, an inventory with hundreds of thousands of spare part numbers, and a series of recent acquisitions, Smurfit Westrock faced challenges in mastering data inconsistencies, such as duplicate materials, language inconsistencies, and synonym-based descriptions (e.g., “lubricant” v
Textron Aviation European Distribution Center Celebrates 10 Years as It Grows Cessna and Beechcraft Parts Availability in Region8.4.2025 10:00:00 CEST | Press release
Textron Aviation today announced its European Distribution Center (EUDC) is celebrating 10 years of proudly serving Cessna, Beechcraft and Hawker customers with parts support in Europe and the Asia-Pacific (APAC) region. Situated in Düsseldorf, Germany, the facility has grown to become the company’s second-largest parts distribution center, fulfilling more than 50 percent of all European parts orders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407038627/en/ Textron Aviation announced its European Distribution Center (EUDC) is celebrating 10 years of proudly serving Cessna, Beechcraft and Hawker customers with parts support in Europe and the Asia-Pacific (APAC) region. (Photo credit: Textron Aviation) Beechcraft, Cessna and Hawker customers receive factory-direct support, maintenance and modifications by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, through a global network of service and part centers, mob
Intelsat Installs Multi-Orbit System on 130 Aircraft, Nearing 1000 Orders8.4.2025 09:00:00 CEST | Press release
Intelsat, operator of the world’s largest integrated satellite and terrestrial networks and leading provider of in-flight connectivity (IFC), installed its pioneering multi-orbit electronically steered array (ESA) system on 130 aircraft, delivering reliable, streaming connectivity to passengers aboard flights throughout North America. Intelsat has secured commitments for 1000 aircraft set to be equipped with the cutting-edge and operational multi-orbit solution. “This milestone underlines the fact that many airlines around the world are gravitating towards multi-orbit inflight connectivity solutions,” said Mike DeMarco, Chief Commercial Officer for Intelsat. “Passengers are already enjoying reliably fast service, based on our airline partners’ satisfaction scores, and we are excited to play a role in their success.” The successful launch of Intelsat's state-of-the-art multi-orbit system represents a major leap forward for in-flight connectivity technology, offering passengers unprecede
DATROWAY® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer8.4.2025 08:30:00 CEST | Press release
First approval in the EU for Daiichi Sankyo and AstraZeneca’s DATROWAY based on TROPION-Breast01 trial showing 37% reduction in the risk of disease progression or death versus chemotherapy Second DXd antibody drug conjugate approved in EU based on Daiichi Sankyo’s DXd technology DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medical Products for Human Use of the European Medicines Age
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom